StockDuty ← Dashboard Oct 28, 2026 08:46 PM ET
SignalCorporate

NeoGenomics Non-GAAP EPS of $0.07 beats by $0.01, revenue of $209.25M beats by $1.92M

NeoGenomics Non-GAAP EPS of $0.07 beats by $0.01, revenue of $209.25M beats by $1.92M

What happened: NeoGenomics (NEO) reported Q3 Non-GAAP EPS of $0.07, beating by $0.01, and revenue of $209.25M, beating by $1.92M. The company also revised its full-year 2026 guidance. Key numbers: Q3 revenue $209.25M, up 11.4% Y/Y. Updated FY 2026 revenue guidance $807M to $809M, versus prior $802M to $806M. FY 2025 revenue actual $727M. Updated FY 2026 net loss guidance $(32)M to $(30)M. Why it matters: The company raised its FY 2026 revenue and net loss outlook compared with previous guidance, with revenue growth of 11% from FY 2025 and adjusted EBITDA of approximately 38%. Coverage: 4 outlets in 24h
NeoGenomics (NEO) reported Q3 Non-GAAP EPS of $0.07, beating by $0.01, and revenue of $209.25M, beating by $1.92M. The company also revised its full-year 2026 guidance.
The company raised its FY 2026 revenue and net loss outlook compared with previous guidance, with revenue growth of 11% from FY 2025 and adjusted EBITDA of approximately 38%.
Sources